medigraphic.com
ISSN 1561-2961 (Print)

2017, Number 1

<< Back Next >>

Rev Cuba Enf 2017; 33 (1)

Cardiovascular risk assessment by applying the table Framingham

Tamayo SE, Sánchez SJM, Estévez RRA, Basset MI

Language: Spanish
References: 20
Page: 149-158
PDF size: 111.03 Kb.


ABSTRACT

Introduction: The World Health Organization states that heart disease and stroke are the leading cause of death worldwide. It is expected to be the leading cause of death and disability in 2020.
Objective: Sistematize applications estimation table Framingham cardiovascular risk, variables and biomarkers of cardiovascular risk.
Methods: A literature review, analysis and categorization of different items in Scielo data bases, Pub Med, Redalyc and Medigraphic, the key terms for the search was conducted were: cardiovascular risk, assessment, and Framingham table; combined with acute myocardial infarction angina and stroke. Those articles published after the year 2005 were set as a limit.
Conclusions: The literature on estimation of cardiovascular risk in healthy populations is moderate and is performed using various tables estimation risk, most of which derive from the Framingham study identified different factors medullary cardiovascular risk such as: age, sex, total cholesterol, HDL cholesterol, blood pressure and smoking, these are universal and inexpensive at the time of being measured, so that the application of this score is one of the most used but not alone. The tools of risk measurement such as the Framingham table, ankle - brachial index, protein c ultra-sensitive, and homocysteine play a fundamental role in primary prevention of cardiovascular disease being necessary to minimize the increase in cardiovascular morbidity and mortality in México and the world.


REFERENCES

  1. Sifuentes Contreras A, Sosa Gil E, Pérez Moreno AR, Parra Falcón FM. Riesgo cardiovascular del personal de enfermería en el área quirúrgica. Enferm. glob. 2011 [citado 2015 Jul 08];10(21):1-10. Disponible en: http://scielo.isciii.es/scielo.php?pid=S169561412011000100005&script=sci_arttext

  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya Kl. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study. Lancet. 2010;380:2095-212.

  3. Instituto Nacional de Estadística Geografía e Informática INEGI 2010.

  4. Guisado Rasco A, Cristobo Sáinz P, Barón Esquivias G. ¿Cuáles son las diferencias entre las funciones para la evaluación del riesgo cardiovascular? Cardiocore. 2012;47(1):12-5.

  5. Vega Abascal Jorge, Guimará Mosqueda Mayra Rosa, Garces Hernández Yodalis, Vega Abascal Luis A, Rivas Estevez Mayelín. Predicción de riesgo coronario y cardiovascular global en la atención primaria de salud. ccm. 2015 [citado 2015 Jul 06];19(2):202-11. Disponible en: http://www.scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560- 43812015000200003&lng=es

  6. Hippisley-Cox Julia, Coupland Carol, Vinogradova Yana, Robson John, Minhas Rubin, Sheikh Aziz, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ. 2008;336:1475.

  7. Giraldo Trujillo J, Martínez JW, Granada Echeverri P. Aplicación de la escala de Framingham en la detección de riesgo cardiovascular en empleados universitarios, 2008. Rev.Salud pública. 2011;13(4):633-43.

  8. Esquivel Solís V, Vinicio Alvarado M, Solano Quiróz G, Ramírez Leandro A. Factores de riesgo cardiovascular en un grupo de mujeres con sobrepeso y obesidad. AMC. 2008;50(4):213-20.

  9. Calderón Mónica A, Aranguren Sandra L, Gerónimo Néstor R, Castañeda Oneida. Factores de riesgo para enfermedad cardiovascular en aspirantes a una empresa de obras civiles en Yopal - Casanare, 2010. Rev. Colomb. Cardiol. 2012 [cited 2015 July 06];19(6):287-8. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120- 56332012000600004&lng=en

  10. Suárez C, Álvarez Sala L,etal. Cálculo del riesgo cardiovascular. MedClin (Barc). 2007;129(14):534-41.

  11. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men. Circulation. 2008;118(22):2243-51. Available from: http://doi.org/10.1161/CIRCULATIONAHA.108.814251

  12. Daniela Luisa Maggi, Leyla Regina DalPiva de Quadros, Karina de Oliveira Azzolin, Silvia Goldmeier. Ankle - brachial index:nurses strategy to cardiovascular disease risk factors identification. Rev.Esc.Enferm. USP. 2014;48(2):221-5.

  13. Fernández Eduardo, García Carlos, de la Espriella Rafael, Dueñas Carmelo R, Manzur Fernando. Biomarcadores cardíacos: presente y futuro. Rev. Colomb. Cardiol. 2012 [cited 2015 July 06];19(6):300-11. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120- 56332012000600006&lng=en

  14. Jacob Fog Bentzon, Fumiyuki Otsuka, Renu Virmani, Erling Falk. Acute Coronary Syndromes Compendium: Mechanisms of Plaque Formation and Rupture. Circ Res. 2014;114(12):1852-66.

  15. Gariglio Luis, Riviere Stephanie, Morales Analía, Porcile Rafael, Potenzoni Miguel, Fridman Osvaldo. Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score. Arch. Cardiol. Méx. 2014 [citado 2015 Jul 06];84(2):71-8. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405- 99402014000200002&lng=es

  16. Bhargava S, Parakh R, Srivastava LM. Studies on homocysteine demonstrating its significance as a possible tool for differential diagnosis in occlusive vascular disease. Indian Journal of Clinical Biochemistry. 2004;19(1):76-8. Available from: http://doi.org/10.1007/BF02872395

  17. Sontakke AN, Tilak MA, Dhat VV, More UM, Shinde SA, Phalak P, et al. Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein "a" in Women. Journal of Clinical and Diagnostic Research : JCDR. 2014;8(10):13-5. Available from: http://doi.org/10.7860/JCDR/2014/9607.4995

  18. Trejo-Gutiérrez Jorge F, López-Jiménez Francisco. Cardiología "basada en la evidencia": aplicaciones prácticas de la epidemiología. II. El uso de biomarcadores. Arch. Cardiol. Méx. 2011 [citado 2015 Jul 06];81(2):158-61. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405- 99402011000200013&lng=es

  19. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, et al. Significance of a Multiple Biomarkers Strategy Including Endothelial Dysfunction to Improve Risk Stratification for Cardiovascular Events in Patients at High Risk for Coronary Heart Disease Journal of the American College of Cardiology. 2009;54(7):601-8.

  20. Colina BV, Padrón ND, Quero GZ. La Homocisteína como factor de riesgo en la enfermedad cardiovascular. Archivos Venezolanos de Farmacología y Terapéutica. 2005 [citado 2016 Mar 22];24(1):1-10. Disponible en: http://redalyc.org/articulo.oa?id=55924103




2020     |     www.medigraphic.com